ADVERTISEMENT
ADVERTISEMENT
mis-c multisystem inflammatory syndrome in children covid-19 coronavirus pandemic sars-cov-2 antibody cardiac inflammation icu intensive care kids infection vomiting abdominal pain diarrhea fever
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021 | 2 min read
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Lisa Winter | Apr 6, 2021 | 2 min read
Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Lisa Winter | Mar 5, 2021 | 2 min read
Instead, the full report will be available in mid-March.
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021 | 2 min read
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.
regeneron monoclonal antibody sars-cov-2 covid-19 pandemic coronavirus neutralization b.1.351 variant south africa REGN10987 casirivimab and REGN10933 imdevimab
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021 | 3 min read
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
Conference Linked to as Many as 300,000 COVID-19 Cases: Study
Lisa Winter | Dec 14, 2020 | 2 min read
Around 100 people were infected at a scientific meeting hosted by Biogen in Boston in February. Then they went back home, taking the virus with them.
Patients Reinfected with Coronavirus in Hong Kong, Europe
Lisa Winter | Aug 25, 2020 | 2 min read
So far, there are three patients known to have been infected with SARS-CoV-2 twice, and in at least one case the second time around was asymptomatic.
COVID-19 Outbreaks Occur as Students Return to Campus
Lisa Winter | Aug 18, 2020 | 7 min read
Following a string of outbreaks, the University of North Carolina at Chapel Hill will move to an online-only semester.
Noel Rose, Immunology, Autoimmune Disease, John Hopkins University, University at Buffalo, Microbiology, Antigens
Noel Rose, Who Demonstrated Autoimmunity Exists, Dies at 92
Amanda Heidt | Aug 10, 2020 | 4 min read
The Johns Hopkins University researcher bucked the prevailing idea that the body would not launch an immune response against its own tissues, and in doing so established an entirely new scientific discipline.
Study: Mask-Wearing Moms with COVID-19 Can Safely Nurse Babies
Lisa Winter | Jul 24, 2020 | 2 min read
None of the breastfed infants in the study tested positive for SARS-CoV-2 within the first two weeks of life.
The Father of Autoimmunity: A Profile of Noel Rose
Diana Kwon | Jun 1, 2020 | 9 min read
By revealing that animals could develop immune responses against their own tissues, the physician-scientist established an entirely new field of science.
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
Lisa Winter | Mar 27, 2020 | 2 min read
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020 | 3 min read
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
Chinese Officials Blame US Army for Coronavirus
Lisa Winter | Mar 13, 2020 | 3 min read
There is no evidence backing the idea that SARS-CoV-2 originated from US servicemembers visiting Wuhan.
College Class Cancellations Skyrocket Amid Coronavirus Concerns
Lisa Winter | Mar 10, 2020 | 9 min read
Dozens of schools across 11 states have announced emergency policies to help curb the spread of COVID-19.
Global COVID-19 Cases Top 100,000
Lisa Winter | Mar 6, 2020 | 3 min read
The WHO chief calls for swift action as universities in multiple countries shut down and researchers report kids can become infected.
The Influence of Soil on Immune Health
Jef Akst | Jan 8, 2020 | 6 min read
Recent work in humans and mice highlights how exposure to environmental microbes helps protect against allergies and other inflammatory diseases.
ADVERTISEMENT